Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma

In an industry first, all ongoing studies migrated to Vault EDC from legacy EDC PLEASANTON, Calif., Jan. 17, 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy…

Click here to view original post